Provider of animal microbiome based diagnostics services for pet care. Provider of animal microbiome based diagnostics services for pet care. The company allows the customers to send the sample through an assessment kit to extract and analyze the DNA to understand the pet's gut microbiome. They send an analysis report which also includes a gut health comparison tool and highlights any abnormal signs in the data. Their scientists can also talk to the pet's veterinarian about the necessary treatment options. The company operates in the Life Sciences > Life Sciences Platforms and Tools, HealthTech > Veterinary HealthTech sector. Founded in 2016 and headquartered in San Francisco, United States and has raised $25.9 million in Series B funding. Key investors include IndieBio, Cargill, SOSV, Moai Capital, Michelson Found Animals, Digitalis Ventures, R/GA, Pet Care Innovation.
AnimalBiome
Series BProvider of animal microbiome based diagnostics services for pet care. Provider of animal microbiome based diagnostics services for pet care. The company allows the customers to send the sample through an assessment kit to extract and analyze the DNA to understand the pet's gut microbiome. They send an analysis report which also includes a gut health comparison tool and highlights any abnormal signs in the data.…
About
Business model
Veterinary HealthTech > In Vitro Diagnostics > Diversified > Microbiome Tests,
Genomics > Applied Genomics > Veterinary Genomics,
Life Sciences Platforms and Tools > Research Services > Genomics > Metagenomics
Team background
College Wise > Yale University
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.